Back to top
more

Fidelity Select Biotechnology: (MF: FBIOX)

(MF) As of Mar 22, 2017 06:05 PM ET

 Add to portfolio

$199.41 USD

+1.56 (0.79%)

Zacks MF Rank 1-Strong Buy 1        

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Latest Performance as of Feb 28, 2017

Total Return %* Percentile Rank Objective
YTD 16.75 1
3 months 10.24 30
6 months 11.27 14
1 Year 29.64 9
3 Year 3.90 76
5 Year 22.18 3
10 Year 15.36 3

* Annual for three years and beyond.

Zacks Premium Research for FBIOX

This is our Mutual Fund rating system that serves as a timeliness indicator for Mutual Fund's over the next 6 months:

Zacks Rank Definition
1 Strong Buy
2 Buy
3 Hold
4 Sell
5 Strong Sell

Zacks Mutual Fund Rank FAQ - Learn more about the Zacks Mutual Fund Rank
Zacks Mutual Fund Rank Home - All Zacks Rank resources in one place
Zacks Premium - The only way to get access to the Zacks Rank

Zacks MF Rank Strong Buy 1
MF Research Report

Mutual Funds Research & Tools

Search Similar Mutual Funds

Research similar Mutual Funds with higher ranks and performance ratings.

Mutual Funds Comparison View (minimum of 2)

Mutual Funds Screener

Narrow down the universe of 18,000+ funds we rank with our robust, yet easy-to-use mutual fund screeners. Select from up to 50 different data points to find the mutual funds that best Screen meet your unique criteria.

Portfolio Statistics

%Unrealized Gain YTD 18.00
% Yield 0.00
% SEC Yield NA
Net Assets (Mil $) 2/28/2017 9,578.16
%Turnover 2/28/2017 35.00

Risk

3 Year 5 Year 10 Year
Beta 1.78 1.46 0.89
Alpha -9.74 3.99 9.88
R Squared 0.37 0.31 0.33
Std. Dev. 30.29 26.70 23.96
Sharpe 0.29 0.99 2.00

Sector / Country Weightings

As of 2/28/2017 % of Portfolio
Health 70.90
Other 15.07
Services 13.35
Industrial Cyclical 0.54
Finance 0.08
Technology 0.06

Portfolio Holdings

Top Equity Holdings
(As of 11/30/2016)
% of Portfolio Value (Mil$)
REGENERON PHARMACEUTICALS 6.29 602.61
ALEXION PHARMACEUTICALS I 6.06 580.75
CELGENE CORP 4.95 474.36
BIOGEN INC 4.31 412.73
SEATTLE GENETICS INC 3.27 313.80
VERTEX PHARMACEUTICALS IN 3.21 307.69
INCYTE PHARMACEUTICALS IN 2.88 276.43
RADIUS HEALTH INC 2.30 220.17
BIOMARIN PHARMACEUTICAL 2.28 218.73

Stock Holding % of Net Assets

As Of 11/30/2016
Total Issues 215
Avg. P/E 34.88
Avg. P/Book 5.87
Avg. EPS Growth 15.5
Avg. Market Value (Mil $) 19,474

Allocation

% of Portfolio
Large Growth 0.00
Large Value 0.00
Small Growth 32.09
Small Value 0.00
Foreign Stock 0.00
Emerging Market 0.00
Precious Metal 0.00
Intermediate Bond 0.00
Foreign Bond 0.00
High Yield Bond 0.00